Everence Capital Management Inc Dynavax Technologies Corp Transaction History
Everence Capital Management Inc
- $1.54 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
287Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$303 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$246 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$127 Million0.0% of portfolio
-
State Street Corp Boston, MA7.79MShares$108 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.56MShares$90.7 Million5.31% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.75B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...